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Abstract: Nanoparticles (NPs) are nano-sized particles (generally 1–100 nm) that can be synthesized
through various methods. The wide range of physicochemical characteristics of NPs permit them to
have diverse biological functions. These particles are versatile and can be adopted into various
applications, particularly in biomedical field. In the past five years, NPs’ roles in biomedical
applications have drawn considerable attentions, and novel NPs with improved functions and
reduced toxicity are continuously increasing. Extensive studies have been carried out in evaluating
antibacterial potentials of NPs. The promising antibacterial effects exhibited by NPs highlight
the potential of developing them into future generation of antimicrobial agents. There are various
methods to synthesize NPs, and each of the method has significant implication on the biological action
of NPs. Among all synthetic methods, green technology is the least toxic biological route, which is
particularly suitable for biomedical applications. This mini-review provides current update on the
antibacterial effects of NPs synthesized by green technology using plants. Underlying challenges in
developing NPs into future antibacterials in clinics are also discussed at the present review.
Keywords: antibacterial; nanoparticles; green synthesis; biomedical applications; plants
1. Nanoparticles and Green Technology
Nanoparticles (NPs), also known as nanomaterials, are small on a molecular scale and have
various physical and chemical properties. Some examples of NPs are made up of metals ions
such as Au, Ag, Pd, Pt, Zn, Fe, and Cu, and metal oxides such as Ag2O, NiO, ZnO, CuO, FeO,
and CeO2. The advancement of nanotechnology has also given rise to the development of various
nanocomposites, which are multiphase solid materials consisting of multiple types of NPs and
polymers to improve single-metal biological effects and overcome structure-function related issues [1].
Multiple biological actions of the NPs such as antibacterial [2,3], antioxidant [2,4], anticancer [5,6],
antifungal [5,7], antiviral [8,9], antiparasitic [10,11] and anti-inflammatory activities [12,13] have been
associated with their highly diverse chemistry-rich characteristics [14]. There are myriad ways of
synthesizing NPs, including physical (e.g., vapor deposition [15], sputter deposition [16], electric arc
deposition [17], ion beam technique [18], molecular beam epitaxy [19], melt mixing [20]), chemical
(e.g., co-precipitation [21], sol-gel [22], microemulsions [23], sonochemical synthesis [24] UV-initiated
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photoreduction [25]), and biological (e.g., synthesis using plant extracts [26], microorganisms [26],
algae [27], fungi [28], animals [29] or agricultural waste [30], enzymes [31]) methods as well as hybrid
methods [32] (Figure 1). There are advantages and limitations for each synthetic method, and the
choice of method is selected based on the downstream applications.
Due to their small size and improved cell-penetrating features, NPs are extremely useful
in various biomedical applications including sensing [33,34], imaging [33,35], diagnostics [36,37],
drug/compound delivery system [38,39], bioconjugation [40,41], hyperthermia [42,43], and biological
therapies [33,36] (Figure 1). In the past few years, NPs have been widely used to improve sensing
and imaging techniques mainly due to their remarkable localization capability [33]. Some other
additional advantages using NPs include flexibility in surface modification of NP [44], easy control of
size [45], and production of highly degradable NPs in vivo [46]. Moreover, NPs are widely used in
bio-conjugation and combination with drugs and compounds as well as in facilitating their delivery to
target [47]. In a review paper authored by Werengowska-Ciec´wier et al., bioconjugation of various
drugs and NPs as well as their detailed chemistry have been described [47]. The same review also
discussed the application of NPs in drug delivery system for targeted therapies. The potential use of
NPs in hyperthermia mainly in cancer cell killing have been extensively explored [48,49]. The use of
magnetic hyperthermia is one of the hot approaches [48,50]. Using magnetic NPs, heat generation can
be controlled and specifically target and kill cancer cells while limiting damage to the surrounding
normal tissue [50,51]. As chemo- and radiotherapies are standard cancer treatments, it is anticipated
that the use of NPs in combination with current treatments could enhance the treatment outcome while
reducing side effects of chemo-and radio-therapies [51]. Similarly, NPs have also been shown to be
effective against other infectious diseases such as Pseudomonas aeruginosa [52] and Escherichia coli [53]
infections in addition to cancers. This highlights the important role of NPs in medical and biomedical
application in short future.
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Figure 1. Current synthetic methods of nanoparticles (NPs) and their biomedical applications. The core
methods used for NPs construction are divided into physical, chemical, and biological methods.
The generated NPs can be utilized in various biomedical applications including imaging, biosensors,
diagnostics, biological therapies, drug delivery, bioconjugation, and hyperthermia.
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Generally, synthesis of NPs by biological routes has several advantages over both physical and
chemical methods. First, the process is relatively simple, easy to scale up, efficient, and it consumes
lesser energy [26]. Second, green technology is environmentally friendly as it uses lesser toxic chemicals
and generating safer products and byproducts [54]. The green method is suitable and applicable for
production of food, pharmaceuticals, and cosmetics [55]. Comparatively, the green method produces
NPs that are generally less toxic, the end products being more suitable for a wide range of biomedical
applications [26,56]. Chemical and physical methods can be very costly and usually involve the use of
toxic and hazardous chemicals which tend to be more toxic to human cells. Additionally, the green
method does not strictly require high temperature, pressure, and energy [57]. However, several
parameters such as pH, chemical concentration, reaction time and reaction temperature are critical to
consistently produce biologically functional NPs [58–61]. Furthermore, unlike using microbial system,
generation of NPs from plants do not have to maintain microbial culture hence reducing the costs for
microorganism isolation and culture media preparation [54]. The NPs generated from plants generally
have size ranging from 1 to 100 nm (Table 1). There are also relatively large NPs that have sizes
ranging from 100 to 500 nm [2,62,63]. NPs generated by all type of methods result in impurities that
mainly cause toxicity to the human cells. These impurities can be removed by dialysis and filtering.
The plant-derived NPs are less toxic, as shown from toxicity testing across several mammalian cell
lines such as NIH3T3 [4], HEK293 [3], and primary cells such as peripheral blood mononuclear cells
(PBMCs) [63] and rat aortic vascular smooth muscle cells (VSMCs) [4].
There is an extensive list of NPs possessing various biological actions as mentioned above.
However, the focus of this review emphasizes the NPs’ antibacterial activities. This short review
provides updates on the recent NPs with promising antibacterial activity synthesized by green
technology using whole plant or other extracts of plants such as leaves [5,63], fruits [64,65], roots [66,67],
barks [62,68], seeds [69,70], rhizomes [71,72], peels [73,74], flowers [75], and callus [76,77]. Here, we also
discuss the challenges of adopting NPs for clinical applications.
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Table 1. Antibacterial effects of nanoparticles synthesized by green method using plants against various bacteria reported in PubMed-indexed publications from 2016 to 2017.
Nanoparticles Size (nm) Source Scientific Name Common Name Target Bacteria References
Ag-NPs
26–28 Leaves Coleus aromaticus Cuban oregano Escherichia coli (E. coli), Staphylococcus aureus (S. aureus) [78]
12.46 Leaves Salvinia molesta Kariba weed E. coli, S. aureus [79]
70.7–192.02 Leaves Aloe vera Aloe Pseudomonas aeruginosa (P. aeruginosa), Streptococcusepidermidis (S. epidermidis) [63]
5–50 Leaves Mentha pulegium Pennyroyal E. coli, S. aureus, Streptococcus pyogenes (S. pyogenes) [5]
5–40 Leaves Cucurbita pepo Summer squash
E. coli, S. aureus, Bacillus cereus (B. cereus), Listeria
monocytogenes (L. monocytogenes), Salmonella typhi (S. typhi),
Salmonella enterica (S. enterica)
[80]
112.6 Crude Ammania baccifera Monarch redstem S. aureus, P. aeruginosa, MRSA [81]
10–70 Oil cake Cocos nucifera Coconut Aeromonas sp., Acinetobacter sp., Citrobacter sp. [82]
3.2–16 Seeds Pimpinella anisum Aniseed
K. pneumonia, P. aeruginosa, S. typhi
Streptococcus pyogenes (S. pyogenes), Acinetobacter baumannii
(A. baumannii)
[69]
2–25 Crude Matricaria camomilia Camomile E. coli, S. aureus, Bacillus subtilis (B. subtilis), P. aeruginosa [83]
50 Crude Salvadora persica L. Toothbrush tree E. coli, S. aureus [84]
25 Rhizomes Zingiber officinale Ginger E. coli, S. aureus, K. pneumonia [71]
20 Leaves Gloriosa superba Flame lily E. coli, B. subtilis [85]
5–25 Leaves Parkia roxburghii Tree bean E. coli, S. aureus [86]
10–20 Tubers Dioscorea alata Yams E. coli, Staphylococcus auricularis (S. auricularis) [87]
35–42.5 Powder Theobroma cacao Cacao E. coli, S. aureus, Staphylococcus epidermidis (S. epidermidis),P. aeruginosa [88]
10–50 Leaves Adathoda vasica Linn Vasaka Vibrio parahaemolyticus (V. parahaemolyticus) [89]
14.63 Crude Eleutherococcus senticosus Siberian ginseng E. coli, S. aureus, V. parahaemolyticusBacillus anthracis (B. anthracis) [90]
20–30 Seeds Coffea arabica Arabian coffee E. coli, S. aureus [70]
20–100 Leaves Sonneratia apetala Sonneratiamangrove
Shigella flexneri (S. flexneri), E. coli, S. aureus, Vibrio cholera
(V. cholera), S. epidermidis, B. subtilis [62]
50–400 Bark Heritiera fomes Sundari E. coli, S. aureus, V. cholera, S. epidermidis, B. subtilis [62]
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Table 1. Cont.
Nanoparticles Size (nm) Source Scientific Name Common Name Target Bacteria References
3–6 Crude Allium sativum L. Garlic E. coli, E. faecalis, Bacillus cereus (B. cereus), S. flexneri [91]
3–22 Crude Zingiber officinale Rosc. Ginger E. coli, E. faecalis, B. cereus, S. flexneri [91]
3–18 Crude Capsicum frutescens L. Cayenne pepper E. coli, E. faecalis, B. cereus, S. flexneri [91]
10–20 Roots Salvadora persica L. Toothbrush tree E. coli, S. aureus, P. aeruginosa, Micrococcus luteus (M. luteus) [92]
5–30 Crude Rumex dentatus Toothed dock P. aeruginosa, Bacillus thuringiensis (B. thuringiensis) [93]
49 Flowers Millettia pinnata Karanja E. coli, P. aeruginosa, Proteus vulgaris (P. vulgaris), S. aureus,K. pneumonia [75]
16.4 Seeds Pongamia pinnata SeashoreMempari E. coli [94]
5–60 Rhizomes Dryopteris crassirhizoma Japanese fern P. aeruginosa, B. cereus [72]
1–69 Leaves Ficus religiosa Peepul tree E. coli, B. subtilis, S. typhi, Pseudomonas fluorescens(P. fluorescens) [95]
12–38 Powder Styrax benzoin Benzoin gum E. coli, P. aeruginosa, S. aureus [96]
6.4–27.2 Callus Taxus yunnanensis Himalayan yew E. coli, S. aureus, S. paratyphi, B. subtilis [76]
10–20 Ginsengberry Panax ginseng Meyer berries E. coli, S. aureus [4]
45.26 Cornleaves Zea mays L. Maize E. coli, S. aureus, S. typhimurium, L. monocytogenes, B. cereus [97]
20–80 Shoot tip Caesalpinia mimosoides Lam. Mimosa thorn E. coli, L. monocytogenes [98]
37 Leaves Coriandrum sativum Coriander Propionibacterium acnes (P. acnes) [99]
22.89 Aerialparts Artemisia tournefortiana - E. coli, B. subtilis, S. pyogenes, P. aeruginosa [100]
20 Leaves Derris trifoliata Common derris E. coli, S. aureus, S. enterica, Vibrio parahaemolyticus(V. parahaemolyticus) [101]
121 Roots Rheum palmatum Chinese Rhubarb S. aureus, P. aeruginosa [66]
12.46 Leaves Salvinia molesta Giant salvinia E. coli, S. aureus [102]
32.5 Roots Decalepis hamiltonii IndianSarsaparilla E. coli, S. aureus, P. aeruginosa, B. cereus, B. licheniformis [67]
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Table 1. Cont.
Nanoparticles Size (nm) Source Scientific Name Common Name Target Bacteria References
16 Crude Heterotheca inuloides Mexican arnica E. coli, S. aureus [103]
10–30 Fruit juices Vitis vinifera and Solanumlycopersicum Grape and tomato
Pseudomonas septica (P. septica), S. aureus, M. luteus,
Enterobacter aerogenes (E. aerogenes), B. subtilis, S. typhi [104]
2.1–45.2 Callus Artemisia annua Sweet wormwood Arthrobacter arilaitensis (A. arilaitensis), Staphylococcusequorum (S. equorum), Microbacterium oxydans (M. oxydans) [77]
15.2 Bark Crataeva nurvala Ayurveda P. aeruginosa [105]
6–8 Fruit Tamarindus indica Tamarind
P. aeruginosa, S. aureus, M. luteus,
Enterobacter aerogenes (E. aerogenes)
B. subtilis, B. cereus, S. typhi
[106]
12–80 Callus Nicotiana tabacum Tobacco E. coli, Agrobacterium rhizogenes (A. rhizogenes) [107]
410–450 Leaves Lantana camara Verbanaceae E. coli, S. aureus, P. aeruginosa [2]
25–40 Crude Actinidia deliciosa Kiwi fruit P. aeruginosa [6]
15–28 Stem bark Ficus krishnae Krishna fig E. coli, S. aureus, S. typhimurium [68]
2–15 Callus Catharanthhus roseus Madagascarperiwinkle E. coli [108]
28 Leaves Convolvulus arvensis Field bindweed E. coli [109]
25 Leaves Artemisia vulgaris Commonwormwood
E. coli, S. aureus, P. aeruginosa, K. pneumonia, Haemophilus
influenza (H. influenza) [110]
20 Leaves Costus afer - E. coli, S. aureus, P. aeruginosa, K. pneumonia, B. subtilis [111]
23–42 Leaves Exocoecaria agallocha Blinding tree P. aeruginosa, S. aureus, S typhi, B. cereus [112]
10–80 Aerialparts Anthemis atropatana - E. coli, S. aureus, P. aeruginosa, S. pyogenes [113]
40–60 Leaves Arbutus unedo Strawberry tree E. coli, S. epidermis, B. subtilis, P. aeruginosa [114]
88.8 Leaves Cicer arietinum Chickpea E. coli, P. aeruginosa [115]
5–30 Leaves Taraxacum officinale Dandelion Xanthomonas axonopodis (X. axonopodis), Pseudomonassyringae (P. syringae) [116]
20–44.49 Leaves Prosopis cinerraria Khejri tree E. coli, K. pneumonia, S. epidermidis [117]
15–25 Leaves Croton bonplandianum Bantulasi E. coli, S. aureus [118]
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Nanoparticles Size (nm) Source Scientific Name Common Name Target Bacteria References
Au-NPs
5–10 Ginsengberry Panax ginseng Meyer berries E. coli, S. aureus [4]
5–25 Leaves Parkia roxburghii Tree bean E. coli, S. aureus [71]
10–75 Leaves Ginkgo biloba Linn Ginkgo tree Brevibacterium linens (B. linens) [119]
3–37 Leaves Nigella arvensis Love-in-a-mist E. coli, S. aureus, P. aeruginosa, Serratia marcescens(S. marcescens), B. subtilis, S. epidermidis [120]
25 Fruit Dimocarpus longan Longan S. aureus, B. subtilis, E. coli [64]
5–25 Leaves Cerasus serrulata Japanese cherry E. coli, S. aureus [121]
7–20 Crude Actinidia deliciosa Kiwi fruit P. aeruginosa [6]
8–25 Peel Citrus maxima Pomelo E. coli, S. aureus [122]
20–30 Crude Coptis chinensis Gold thread Drug-resistant E. coli [123]
Ag2O-NPs 42.7 Roots Ficus benghalensis Banyan Streptococcus mutans (S. mutans), Lactobacilli sp. [124]
NiO-NPs
9.69 Crude Moringa oleifera Drumstick tree S. aureus, S. pneumonia, Escherichia hermannii (E. hermannii),E. coli [125]
10–20 Leaves Eucalyptus globulus Blue glum E. coli, S. aureus, MRSA, P. aeruginosa [126]
ZnO-NPs
20.06 Leaves Prunus x yedoensisMatsumura Yoshino cherry B. linens, S. epidermidis [127]
400–500 Leaves Sonneratia apetala Sonneratiamangrove S. flexneri [62]
47.27 Leaves Laurus nobilis Bay tree S. aureus, P. aeruginosa [128]
50 Fruit Rosa canina Dog rose E. coli, L. monocytogenes, P. aeruginosa [65]
- Leaves Lobelia leschenaultiana Lobelia P. aeruginosa, Shigella sonnei (S. sonnei), P. vulgaris,V. parahaemolyticus [129]
27–85 Fruit, seed,and pulp Citrullus colocynthis L. Schrad MRSA, P. aeruginosa, E. coli, B. subtilis [130]
Cu-NPs
21–30 Leaves Terminalia catappa Tropical almond E. coli [131]
18.9–32.09 Leaves Prosopis cineraria Khejri tree E. coli, K. pneumonia, S. epidermidis [117]
CuO-NPs 30 –222.5 Leaves Seidlitzia rosmarinus Keliab E. coli, S. aureus [132]
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Table 1. Cont.
Nanoparticles Size (nm) Source Scientific Name Common Name Target Bacteria References
Pt-NPs 2–7 Crude Taraxacum laevigatum Red-seededdandelion P. aeruginosa, B. subtilis [133]
FeO-NPs - Peel Punica granatum Pomegranate P. aeruginosa [134]
Pd-NPs
5 Leaves Sapium sebiferum Chinese tallowtree
S. aureus, P. aeruginosa
Bacillus subtilis [135]
30 Seeds Phyllanthus emblica IndianGooseberry
S. aureus, P. aeruginosa, B subtilis
Proteus mirabilis [136]
27 Peel Moringa oleifera Horseradish tree E. coli, S. aureus [73]
CeO2-NPs
45 Peel Moringa oleifera Horseradish tree E. coli, S. aureus [74]
24 Leaves Olea europaea Olive E. coli, S. aureus, K. pneumonia, P. aeruginosa [137]
Ce2O3-NPs 8.6–10.5 Crude Euphorbia amygdaloides Wood spurge Pediococcus acidilactici (P. acidilactici) [138]
Pectin/Ag-NPs 20–80 Shoot tip Caesalpinia mimosoides Lam. Mimosa thorn E. coli, L. monocytogenes [98]
Ag/Ag2O-NPs 8.2–20.5 Leaves Eupatorium odoratum Christmas bush E. coli, S. typhi, S. aureus, B. subtilis [139]
Ag/Au-NPs 10 Leaves Gloriosa superba Flame lily E. coli, B. subtilis [85]
Chitosan/Ag-NPs 378–402 Crude Rumex dentatus Toothed dock P. aeruginosa, B. thuringiensis [140]
Chitosan/CeO2-NPs 3.61–24.4 Leaves Sida acuta
Common
wireweed E. coli, B. subtilis [141]
PCL/Cur/GLE-Ag-NPs 200 Leaves Vitis vinifera Grape E. coli, S. aureus, P. aeruginosa, B. subtilis, S. enterica [93]
GLE-Ag-NPs 30 Leaves Vitis vinifera Grape E. coli, S. aureus, P. aeruginosa, B. subtilis, S. enterica [93]
Cellulose/Cu-NPs 20–40 Leaves Terminalia catappa Tropical almond E. coli [131]
Ag-MnO2-NPs 5–40 Leaves Cucurbita pepo Summer squash
E. coli, S. aureus, B. cereus, L. monocytogenes, S. typhi,
S. enterica [142]
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2. Bactericidal Properties and Synergistic Enhancement of Common Antibiotics
NPs derived from plants that show promising antibacterial activities have high potential to
be developed into future antibacterials mainly due to their low toxic effects [143]. NPs have
been previously reported to inhibit gram-positive bacteria such as Staphylococcus spp. [4,5],
Streptococcus spp. [113,124], and Bacillus spp. [114,120], and gram-negative bacteria such as
Escherichia spp. [97,122], Pseudomonas spp. [6,68], Salmonella spp. [68,104], Shigella spp. [97,129],
Proteus spp. [75,136], and Vibrio spp. [101,129]. More promisingly, NPs have also been shown to inhibit
antibiotic-resistant bacteria such as Methicillin-resistant S. aureus (MRSA) [81,130] and drug-resistant
E. coli [123]. Table 1 summaries the antibacterial action of NPs reported in PubMed-indexed journals
in the past two years (2016–2017). A total of 107 articles was obtained from Pub-Med search
engine through National Center for Biotechnology Information (NCBI) website using four keywords
(nanoparticles, green synthesis, plant, and antibacterial) [144]. Out of the 107, 17 articles have been
excluded as they do not contain relevant information for this review. These articles included retracted
papers, review papers, and other non-plant-derived NP research papers. The remaining 90 articles
are reviewed, and the information is tabulated in Table 1 and categorized based on the type of NPs.
Since there are various synthetic methods to generate NPs as mentioned in Section 1, the protocol of
constructing the NPs tabulated in Table 1 is different from one to another even though they are derived
from the same part of extracts. Overall, the most reported NPs are Ag-NPs, Au-NPs, followed by other
metal/metal oxide-based NPs and nanocomposites. Most of the NPs have size of less than 100 nm
except for a few NPs as shown in Table 1 [2,62,63,81]. From Table 1, it is also shown that most of the
NPs were produced from the plant’s leaves rather than other parts of the plants, regardless of type
of NPs.
Table 2 shows both gram-positive and gram-negative bacterial species that have been targeted by
various NPs, and the frequency of bacterial species being studied is tabulated. Gram-negative species
that have been targeted the most are E. coli followed by P. aeruginosa, whereas gram-positive species
that are mostly targeted are S. aureus followed by B. subtilis and B. cereus. Comparatively, the type and
total number of gram-negative bacterial species that are being targeted are more than gram-positive
species. This highlights the potential of NPs as antibacterial agents since they could effectively permeate
and kill gram-negative bacterial species which are notorious of their difficult-to-penetrate multilayer
membranes [145]. This notion can be further supported by recent finding by Acharya et al. which showed
a potent killing of AgNPs towards K. pneumonia [146]. FE-SEM analysis demonstrated that the NPs
overlaid with K. pneumonia with damaged cell surfaces and disrupted cells due to the interaction with
NPs. Similarly, it has also been shown by SEM that AgNPs damaged E. coli by causing a large leakage
on cell membrane and the bacteria were disorganized to several parts [147]. The potent antibacterial
killings of NPs demonstrate their potential to be developed into antibacterials against gut-related bacteria
(e.g., E. coli, P. aeruginosa, B. cereus, K. pneumoniae, S. flexneri, and S. typhi) and skin infection–related
bacteria (S. aureus). The collective findings from Table 2 also show that Ag-NPs are the most bactericidal
NPs against the gut bacteria such as E. coli, P. aeruginosa, B. cereus, K. pneumoniae, S. flexneri, S. pyogenes,
S. typhi) and skin-related bacteria such as S. aureus and S. epidermidis. Followed by Ag-NPs, Au-NPs were
reported to be effective in killing E. coli and S. aureus. Interestingly, Table 2 shows that some specific types
of NPs were more effective against a particular bacterial type compared to others. For example, ZnO-NPs
was effective against P. aeruginosa while Pd-NPs was effective against S. aureus.
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Table 2. Gram-negative and gram-positive bacterial species targeted by NPs synthesized from plants via green technology.
Gram-Negative Species Ag Au Cu Pt Pd Ag2O NiO ZnO CuO FeO CeO2 Ce2O3
E. coli 46 6 2 - 1 - 2 2 1 - 2 -
Drug-resistant E. coli - 1 - - - - - - - - - -
E. hermannii - - - - - - 1 - - - - -
P. fluorescens 1 - - - - - - - - - - -
P. aeruginosa 23 2 - 1 2 - 1 4 - 1 1 -
P. syringae 1 - - - - - - - - - - -
P. septica 1 - - - - - - - - - - -
K. pneumoniae 6 - 1 - - - - - - - 1 -
P. vulgaris 1 - - - - - - 1 - - - -
P. mirabilis - - - - 1 - - - - - - -
S. flexneri 4 - - - - - - 1 - - - -
S. sonnei - - - - - - - 1 - - - -
S. paratyphi 1 - - - - - - - - - - -
S. typhi 6 - - - - - - - - - - -
S. typhimurium 2 - - - - - - - - - - -
S. enterica 2 - - - - - - - - - - -
V. parahaemolyticus 3 - - - - - - 1 - - - -
V. cholera 2 - - - - - - - - - - -
Aeromonas sp. 1 - - - - - - - - - - -
Acinetobacter sp. 1 - - - - - - - - - - -
A. baumannii 1 - - - - - - - - - - -
Citrobacter sp. 1 - - - - - - - - - - -
E. aerogenes 2 - - - - - - - - - - -
A. rhizogenes 1 - - - - - - - - - - -
H. influenza 1 - - - - - - - - - - -
X. axonopodis 1 - - - - - - - - - - -
S. marcescens - 1 - - - - - - - - - -
Lactobacilli sp. - - - - - 1 - - - - - -
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Table 2. Cont.
Gram-Positive Species Ag Au Cu Pt Pd Ag2O NiO ZnO CuO FeO CeO2 Ce2O3
S. aureus 35 6 - - 3 - 2 1 1 - 2 -
S. epidermidis 5 1 1 - - - - 1 - - - -
MRSA 1 - - - - - 1 1 - - - -
S. pyogenes 4 - - - - - - - - - - -
S. mutans - - - - - 1 - - - - - -
S. pneumonia - - - - - - 1 - - - - -
B. thuringiensis 1 - - - - - - - - - - -
B. cereus 9 - - - - - - - - - - -
B. subtilis 11 2 - 1 2 - - 1 - - - -
B. licheniformis 1 - - - - - - - - - - -
B. anthracis 1 - - - - - - - - - - -
E. faecalis 3 - - - - - - - - - - -
L. monocytogenes 3 - - - - - - 1 - - - -
M. luteus 3 - - - - - - - - - - -
P. acnes 1 - - - - - - - - - - -
A. arilaitensis 1 - - - - - - - - - - -
M. oxydans 1 - - - - - - - - - - -
B. linens - 1 - - - - - 1 - - - -
P. acidilactici - - - - - - - - - - - 1
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In addition to exhibiting antibacterial effects, NPs derived from plants can also serve as carriers
to deliver antibacterial molecules or drugs to the target cells either via conjugation or nanoemulsions,
hence synergistically enhance the antibacterial effect [97,139]. For example, Kalita and coworkers
demonstrated that a gold NP was able to enhance the bacterial killing effects of Amoxicillin
against both gram-positive (Staphylococcus spp. And Bacillus spp.) and gram-negative bacteria
(E. coli) [139]. Patra and colleagues reported the potential of silver NP synthesized from corn leaves of
Zea mays in foodborne pathogenic bacterial killings when used in combination with Kanamycin and
Rifampicin [97]. More interestingly, the NP was able to reverse the development of antibiotics resistance
by killing MRSA clinical isolates in vitro and in vivo using murine MRSA infection models [148].
The exact mechanism of NPs’ synergism with antibiotics remains exploratory. It could be due
to (a) generation of additional bactericidal Ag+ ions by NPs [149], (b) generation of bactericidal
hydroxyl radicals by NPs [150], and (c) effective blocking of the efflux pump for drug-resistant bacterial
killing [143]. This synergistic effect could ultimately help in reducing the dosage of antibacterials that
may potentially toxic to host system.
The exact mechanisms of NPs against various bacteria remain unknown. There have been several
studies supporting the possible mechanisms of bactericidal effects including (a) attachment of large
number of NPs on bacterial surface that interrupts respiration and other permeability-dependent
functions [97], (b) generation of electrostatic attraction between negatively charged bacterial cells and
the positively charged NPs [151], (c) inactivation and degradation of bacterial essential proteins [152],
and (d) breakage or damage of bacterial genes following the efficient penetration of NPs [153].
For example, it has been shown that silver NPs permeated into bacterial cells and resulted in significant
DNA damages by interacting with sulphur- and phosphorus-containing compounds [154,155].
Similarly, it has also been shown that silver NPs released highly reactive Ag+ ions and radicals for
the antibacterial effects [156]. These ions have also been reported to interact with sulphur-containing
proteins in the bacterial cell wall that caused multiple functionality impairs [152]. Raffi and colleagues
also showed that the silver NPs could inactivate the bacterial enzymes and generate toxic hydrogen
peroxide leading to bacterial cell death [157].
3. Plant-derived Nanoparticles as Future Antibacterials
To date, numerous NPs have been approved by either Food and Drug Administration (FDA)
in United States, or European Medicines Agency (EMA) in the European Union for various clinical
applications including imaging (e.g., Resovist), iron-replacement therapy for anaemia treatment
(e.g., Vifor), delivery of anticancer drugs (e.g., Onivyde and MEPACT) [158,159], vaccines for viral
diseases (e.g., Epaval against hepatitis A and Inflexal V against influenza) [160,161], fungal infection
(e.g., AmBisome) [162], and so on. However, none of the currently approved NPs are used for
controlling bacterial infection [163]. The only liposomal NP formulations that is undergoing clinical
trial is CAL02, which has been designed for bacterial pneumonia management [163]. In this section,
we discuss the potential challenges of developing NPs into clinically approved antimicrobial agents.
Table 3 summaries some of the limitations and challenges of using plant-derived NPs for antimicrobials
development. Undoubtedly, the nano-scale size of NPs has facilitated the cell-penetrating capacity
including crossing blood-brain barrier (BBB) [164,165], hence improving the target specificity and
biological activity. However, the small size may be one of the challenges in the clinical trials. It has
been reported that NPs have poor stability and bioavailability under physiological conditions when
they are administered into host system [166]. Studies have shown that NPs have been targeted
and degraded by various enzymes and proteins from human blood before reaching to target
sites [167,168]. These significantly reduced the biological functions of NPs. To overcome this limitation,
several modification methods have been adopted such as conjugation with stabilizer (e.g., serum
albumin) [169,170], synthesis of stable nanoemulsions [169,170], modification of surface chemistry and
functionalization [171], and development of composite NPs [172]. In addition to size, it has also been
reported that the NPs’ shape and morphology could determine their biological actions and toxicity
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profile [172–174]. Some NPs have high tendency to form aggregates as a result of the particle surface
chemistry. This may cause unwanted toxicity and drastically limit the access of NPs into the target
cells [175]. Toxicity is also attributed to several characteristics of NPs (e.g., chemistry, retention rate,
biodistribution, stability, and specificity), mode of administration, and target sites [176].
There are numerous limitations for NPs productions for biomedical application (summarized
in Table 3). As the biological functions of NPs highly depend on their shape, size, permeability,
and physicochemical properties, manufacturing NPs in industrial scale must strictly adhere to
the tight-controlled, consistent, and reproducible standard operating procedure (SOP) and Good
Manufacturing Practice (GMP). Another challenge is the heterogeneity of diseases in human.
The clinical effect of NPs on infected humans could be very complicated as different individuals present
varied profiles (mainly due to the individual’s immunity) even though they have been infected from
the same source. This will require detailed and organized planning to validate the clinical value of NPs.
Following the increase of potential NPs, the experimental design that requires high throughput setup
for biological screening is also increasingly demanding. This is also closely linked with automation
that allows cost-effective NPs production and, computing and modelling technology that would
predict NPs’ efficacies or toxicities on target cells. The improvement in high throughput screening and
computation will surely boost the development of nanotechnology in biomedical applications.
From an industrial point of view, the chosen synthesis method of NPs-based antibacterials must
be compatible for large-scale production. As most NPs possess complex chemical make-up and
arrangement of components, retaining these key characteristics in the process of scaling up remains
a huge challenge in the manufacturing field. Secondly, the production method has to consistently
produce high quality (e.g., size, uniformity, and physicochemical properties) of NPs. The formulation
process must be recorded meticulously to ensure high-level of reproducibility. The advancement
of modern technology contributed from large high-tech companies and academia will continuously
support the production of high-quality NPs in a consistent and timely fashion.
Table 3. Challenges of developing nanoparticles into clinically used antibacterial agents.
Structural Challenge
Size Smaller size enhances the cell penetration, but may have decreasedstability or bioavailability
Shape Certain shape of NPs may improve the functionality due to total surfaceexposure area
Aggregate NPs that form aggregate increase the overall particle size, hence limitingthe cell permeation and may increase toxicity
Biological Challenge
Biodistribution Poor dispersion due to limited entry (e.g., skin barrier)
Bioavailability Poor bioavailability results in rapid loss of function
Specificity High specificity results in less off-target effects and more effective
Clearance High retention rate ensures the high efficiency
Toxicity Accumulation of toxic materials may damage the host
Technological Challenge
Heterogeneity of human disease Variation within disease may complicate treatment
Scale-up Optimization of NPs synthesis and production with uniform sizewithout aggregates in controlled and consistent fashion
Throughput Synthesis of NP is multistep and laborious which does not allowhigh-throughput optimization
Prediction Prediction using computer modelling on NP efficiency isextremely challenging
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Table 3. Cont.
Industrial Challenge
Quantity Large scale production may result in inconsistent size andphysicochemical properties of NPs
Processes Reproducible and consistent manufacturing processes requires moderntechnology and instrumentation
Quality Continuous production of high level uniformity and functionalityof NPs
4. Conclusions and Future Perspectives
This mini-review provides a recent update on the NPs derived from plants that possess promising
antibacterial action. Antibacterial NPs produced from green technology have great potential to be
developed into future antibacterials and are able to synergistically enhance the efficacy of antibiotics.
While the exact mechanisms remain unknown, a great effort is currently underway to produce a
highly potent and robust NPs for clinical use. Understanding the bactericidal mechanism of NPs
is also important to control and overcome the emerging issue of bacterial resistance to NPs [177].
As highlighted above, the limitations and potential challenges need to be overcome to maximize the
use of NPs to clinical applications. Uniformity, stability, specificity, and toxicity of NPs are the main
biological properties in deciding the fate of NPs in clinical application. From an industrial perspective,
the development of sustainable process and modern instrumentation is crucial to produce a practical
amount of NPs for clinical use [178]. The advancement of nanotechnology and biotechnology are
anticipated to boost the use of NPs in biomedical applications in the future.
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